2025
Personal Narratives in Trauma-Related Disorders: Contributions from a Metacognitive Approach and Treatment Considerations
Wiesepape C, Smith E, Muth A, Faith L. Personal Narratives in Trauma-Related Disorders: Contributions from a Metacognitive Approach and Treatment Considerations. Behavioral Sciences 2025, 15: 150. PMID: 40001781, PMCID: PMC11851491, DOI: 10.3390/bs15020150.Peer-Reviewed Original ResearchTrauma-related disordersTrauma narrativesTraumatic experiencesTreatment of trauma-related disordersIntegrated model of metacognitionIntegration of traumatic experiencesStudy of metacognitionModel of metacognitionSignificant life eventsPersonal narrativesLife eventsNarrative cohesionMetacognitive approachMetacognitionClinical implicationsNarrative identityTreatment considerationsLife narrativesCompleted treatment
2023
Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists
Madanat Y, Zeidan A. Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists. Clinics In Laboratory Medicine 2023, 43: 685-698. PMID: 37865511, DOI: 10.1016/j.cll.2023.07.003.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsBone marrow biopsy reportsAvailable treatment optionsBest therapeutic approachClinical presentationPathologic findingsRisk stratificationTherapeutic optionsTreatment optionsBiopsy reportsDisease entityTherapeutic approachesTreatment considerationsAccurate diagnosisGenetic abnormalitiesDiagnosisDisease subclassificationPatientsNeoplasmsHematopathologistsOptionsPrognosticationAbnormalitiesCliniciansSubclassification
2022
Right heart thrombi (RHT) and clot in transit with concomitant PE management: Approach and considerations
Khosla A, Mojibian H, Assi R, Tantawy H, Singh I, Pollak J. Right heart thrombi (RHT) and clot in transit with concomitant PE management: Approach and considerations. Pulmonary Circulation 2022, 12: e12080. PMID: 35514771, PMCID: PMC9063956, DOI: 10.1002/pul2.12080.Peer-Reviewed Original ResearchRight heart thrombusConcomitant pulmonary embolismPulmonary embolismHeart thrombusTreatment strategiesLimited clinical dataMultiple treatment strategiesMultiple medical specialtiesSystemic thrombolysisSurgical therapyExact incidenceRisk stratificationPoor outcomeUse of pointClinical dilemmaClinical dataTreatment considerationsPE managementCare ultrasoundMultiple specialtiesMedical specialtiesThrombusSpecialtiesAnticoagulationThrombolysisNCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022.
Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, Bello CM, Benitez CM, Chen W, Dabaja B, Daly ME, Gordon LI, Hansen N, Herrera AF, Hochberg EP, Johnston PB, Kaminski MS, Kelsey CR, Kenkre VP, Khan N, Lynch RC, Maddocks K, McConathy J, Metzger M, Morgan D, Mulroney C, Pullarkat ST, Rabinovitch R, Rosenspire KC, Seropian S, Tao R, Torka P, Winter JN, Yahalom J, Yang JC, Burns JL, Campbell M, Sundar H. NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022. Journal Of The National Comprehensive Cancer Network 2022, 20: 322-334. PMID: 35390768, DOI: 10.6004/jnccn.2022.0021.Peer-Reviewed Original ResearchConceptsHodgkin's lymphomaNCCN guidelinesClassical HLNodular lymphocyte predominant Hodgkin lymphomaLymphocyte predominant Hodgkin lymphomaNCCN Guidelines InsightsModern treatment optionsManagement of patientsB-cell originClassical Hodgkin lymphomaLong-term toxicityUncommon malignancyCure rateTreatment optionsTreatment considerationsDose constraintsLymphomaRecent updatesGuidelinesPatientsMalignancy
2020
Commentary on “A New Onset of Mania in a 49-Year-Old Man: An Interesting Case of Wilson Disease”
Garakani A. Commentary on “A New Onset of Mania in a 49-Year-Old Man: An Interesting Case of Wilson Disease”. Journal Of Psychiatric Practice 2020, 26: 510-517. PMID: 33275389, DOI: 10.1097/pra.0000000000000507.Commentaries, Editorials and LettersConceptsPrimary psychiatric disordersYears of ageWilson's diseasePsychiatric disordersNew onsetDiagnostic workupAcute cognitive declineFormal psychiatric historyCommon clinical manifestationsNeurological side effectsFurther diagnostic workupLow serum ceruloplasminMagnetic resonance imagingSecondary maniaAtypical presentationClinical manifestationsHepatic abnormalitiesPsychiatric providersPatient presentationMetabolism disordersBrain abnormalitiesPsychiatric symptomsTreatment considerationsCorrect diagnosisPsychiatric historyTreatment Considerations in the Radiologically Isolated Syndrome
Makhani N. Treatment Considerations in the Radiologically Isolated Syndrome. Current Treatment Options In Neurology 2020, 22: 3. PMID: 32009206, DOI: 10.1007/s11940-020-0608-8.Peer-Reviewed Original ResearchClinical intervention trialsMultiple sclerosisIntervention trialsClinical neurological symptomsFirst clinical eventDisease-modifying therapiesDisease-modifying treatmentsIsolated SyndromeNeurological eventsNeurological symptomsClinical eventsClinical trialsRecent FindingsIndividualsTreatment considerationsTherapeutic interventionsAccurate diagnosisBeneficial effectsTrialsSclerosisSuch interventionsSyndromeSubsequent developmentDiagnosisInterventionTherapy
2019
Lobular neutrophilic panniculitis associated with DNA methyltransferase inhibitors in the treatment of myeloid disease
Coleman E, Panse G, Cowper S, Prebet T, Gore S, Leventhal J. Lobular neutrophilic panniculitis associated with DNA methyltransferase inhibitors in the treatment of myeloid disease. Journal Of Cutaneous Pathology 2019, 46: 930-934. PMID: 31254406, DOI: 10.1111/cup.13537.Peer-Reviewed Original ResearchConceptsLobular neutrophilic panniculitisNeutrophilic panniculitisDNA methyltransferase inhibitorNeutrophilic eccrine hidradenitisInjection site reactionsAcute myelogenous leukemiaMethyltransferase inhibitorNeutrophilic dermatosisSweet's syndromeMaculopapular eruptionCutaneous toxicityHistopathologic characteristicsSite reactionsNext-generation agentsDifferential diagnosisMyelogenous leukemiaTreatment considerationsMyeloid diseasesPanniculitisTreatmentInhibitorsFirst reportGangrenosumHidradenitisEcchymosisChapter 23 Special Treatment Considerations for Wilson Disease
Camarata M, Weiss K, Schilsky M. Chapter 23 Special Treatment Considerations for Wilson Disease. 2019, 235-245. DOI: 10.1016/b978-0-12-811077-5.00023-2.Peer-Reviewed Original Research
2018
Psychiatric Aspects of Wilson Disease
Munjal S, Zimbrean P. Psychiatric Aspects of Wilson Disease. Clinical Gastroenterology 2018, 121-142. DOI: 10.1007/978-3-319-91527-2_7.Peer-Reviewed Original ResearchAssessment and Treatment Considerations for Post Traumatic Stress Disorder at End of Life
Glick DM, Cook JM, Moye J, Kaiser AP. Assessment and Treatment Considerations for Post Traumatic Stress Disorder at End of Life. American Journal Of Hospice And Palliative Medicine® 2018, 35: 1133-1139. PMID: 29463090, PMCID: PMC6546161, DOI: 10.1177/1049909118756656.Peer-Reviewed Original ResearchConceptsEnd of lifeTraumatic Stress DisorderEvidence-based trauma-focused treatmentsStress disorderPost-traumatic stress disorderTrauma-focused treatmentPatient populationManifestations of PTSDTreatment considerationsCare providersTreatment approachesNontraditional treatment approachesClinical implicationsPatientsTreatment issuesLack of awarenessPTSDCurrent reviewTraditional psychotherapyDisordersAdditional benefitMental staminaLatter populationPopulationComorbidities
2008
Collision Tumor of the Large Bowel in the Context of Advanced Pregnancy and Ulcerative Colitis
Duffy A, Shia J, Klimstra D, Temple L, O'Reilly E. Collision Tumor of the Large Bowel in the Context of Advanced Pregnancy and Ulcerative Colitis. Clinical Colorectal Cancer 2008, 7: 402-405. PMID: 19036694, DOI: 10.3816/ccc.2008.n.054.Peer-Reviewed Original Research
2006
Fatal Factitious Cushing’s Syndrome and Invasive Aspergillosis: Case Report and Review of Literature
Kansagara DL, Tetrault J, Hamill C, Moore C, Olson B. Fatal Factitious Cushing’s Syndrome and Invasive Aspergillosis: Case Report and Review of Literature. Endocrine Practice 2006, 12: 651-655. PMID: 17229661, DOI: 10.4158/ep.12.6.651.Peer-Reviewed Case Reports and Technical NotesConceptsFactitious Cushing's syndromeCushing's syndromeInvasive aspergillosisDiffuse pulmonary infiltratesUntreated Cushing's syndromeFatal septic shockInvasive pulmonary aspergillosisMechanism of immunosuppressionInvasive fungal infectionsHealth care providersReview of literaturePulmonary infiltratesFulminant infectionSeptic shockImmunologic aspectsPulmonary aspergillosisClinical findingsCase reportFatal conditionDifficult diagnosisAdrenal cortexTreatment considerationsFactitious illnessPatient's homeSyndrome
2003
Selective immmunotherapy through extracorporeal photochemotherapy: yesterday, today, and tomorrow
Girardi M, Knobler R, Edelson R. Selective immmunotherapy through extracorporeal photochemotherapy: yesterday, today, and tomorrow. Hematology/Oncology Clinics Of North America 2003, 17: 1391-1403. PMID: 14710891, DOI: 10.1016/s0889-8588(03)00106-0.Peer-Reviewed Original ResearchConceptsLow side effect profileSide effect profilePotential novel strategyMechanism of actionImmunosuppressive medicationsExtracorporeal photochemotherapyEffect profileTransplant rejectionTreatment of cancerClinical recordsRole of ECPClinical studiesT cellsTreatment considerationsModern therapeuticsTreatmentNovel strategyGVHDMedicationsAutoimmunityCTCLMalignancyECPTherapyCancer
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply